Novo Nordisk
NVO
#51
Rank
$205.62 B
Marketcap
๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Country
$0.90
Share price
0.43%
Change (1 day)
25.40%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2021 (TTM): $8.86 B

According to Novo Nordisk's latest financial reports the company's current earnings (TTM) are $8.86 B. In 2020 the company made an earning of $8.79 B an increase over its 2019 earnings that were of $8.01 B. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Novo Nordisk from 2001 to 2021

Year Earnings Change
2021 (TTM)$8.86 B0.78%
2020$8.79 B9.73%
2019$8.01 B2.08%
2018$7.85 B-1.24%
2017$7.94 B1.27%
2016$7.84 B9.13%
2015$7.19 B28.25%
2014$5.60 B4.73%
2013$5.35 B9.8%
2012$4.87 B29.72%
2011$3.75 B12.49%
2010$3.34 B33.37%
2009$2.50 B22.86%
2008$2.03 B38.51%
2007$1.47 B-1.78%
2006$1.49 B12.94%
2005$1.32 B18.1%
2004$1.12 B7.89%
2003$1.04 B20.88%
2002$0.86 B-14.39%
2001$1.00 B